127 related articles for article (PubMed ID: 34823731)
1. Harm Reduction in Health Care Settings.
Chan CA; Canver B; McNeil R; Sue KL
Med Clin North Am; 2022 Jan; 106(1):201-217. PubMed ID: 34823731
[TBL] [Abstract][Full Text] [Related]
2. Substance use patterns, sociodemographics, and health profiles of harm reduction service recipients in Burlington, Vermont.
Erath TG; LaCroix R; O'Keefe E; Higgins ST; Rawson RA
Harm Reduct J; 2024 Apr; 21(1):76. PubMed ID: 38580997
[TBL] [Abstract][Full Text] [Related]
3. Correlates of concurrent use of stimulants and opioids among people who access harm reduction services in British Columbia, Canada: Findings from the 2019 Harm Reduction Client Survey.
Lukac CD; Steinberg A; Papamihali K; Mehta A; Lock K; Buxton JA
Int J Drug Policy; 2022 Apr; 102():103602. PubMed ID: 35124412
[TBL] [Abstract][Full Text] [Related]
4. Reducing Fatal Opioid Overdose: Prevention, Treatment and Harm Reduction Strategies.
Hawk KF; Vaca FE; D'Onofrio G
Yale J Biol Med; 2015 Sep; 88(3):235-45. PubMed ID: 26339206
[TBL] [Abstract][Full Text] [Related]
5. Unintentional overdoses: understanding the fentanyl landscape and reducing harm.
Bell LA; Hadland SE
Curr Opin Pediatr; 2023 Aug; 35(4):408-414. PubMed ID: 36974444
[TBL] [Abstract][Full Text] [Related]
6. 'Communities are attempting to tackle the crisis': a scoping review on community plans to prevent and reduce opioid-related harms.
Leece P; Khorasheh T; Paul N; Keller-Olaman S; Massarella S; Caldwell J; Parkinson M; Strike C; Taha S; Penney G; Henderson R; Manson H
BMJ Open; 2019 Sep; 9(9):e028583. PubMed ID: 31515417
[TBL] [Abstract][Full Text] [Related]
7. Perspectives on rapid fentanyl test strips as a harm reduction practice among young adults who use drugs: a qualitative study.
Goldman JE; Waye KM; Periera KA; Krieger MS; Yedinak JL; Marshall BDL
Harm Reduct J; 2019 Jan; 16(1):3. PubMed ID: 30621699
[TBL] [Abstract][Full Text] [Related]
8. Opportunities for Prevention and Intervention of Opioid Overdose in the Emergency Department.
Houry DE; Haegerich TM; Vivolo-Kantor A
Ann Emerg Med; 2018 Jun; 71(6):688-690. PubMed ID: 29523371
[No Abstract] [Full Text] [Related]
9. Integrating Harm Reduction into Outpatient Opioid Use Disorder Treatment Settings : Harm Reduction in Outpatient Addiction Treatment.
Taylor JL; Johnson S; Cruz R; Gray JR; Schiff D; Bagley SM
J Gen Intern Med; 2021 Dec; 36(12):3810-3819. PubMed ID: 34159545
[TBL] [Abstract][Full Text] [Related]
10. Opioid harm reduction: A scoping review of physician and system-level gaps in knowledge, education, and practice.
Gugala E; Briggs O; Moczygemba LR; Brown CM; Hill LG
Subst Abus; 2022; 43(1):972-987. PubMed ID: 35426772
[No Abstract] [Full Text] [Related]
11. How Should Harm Reduction Be Included in Care Continua for Patients With Opioid Use Disorder?
Salisbury-Afshar E; Livingston CJ; Bluthenthal RN
AMA J Ethics; 2024 Jul; 26(7):E562-571. PubMed ID: 38958425
[TBL] [Abstract][Full Text] [Related]
12. Situating the Continuum of Overdose Risk in the Social Determinants of Health: A New Conceptual Framework.
Park JN; Rouhani S; Beletsky L; Vincent L; Saloner B; Sherman SG
Milbank Q; 2020 Sep; 98(3):700-746. PubMed ID: 32808709
[TBL] [Abstract][Full Text] [Related]
13. Support, don't punish: Drug decriminalization is harm reduction.
Bratberg JP; Simmons A; Arya V; Bhatia A; Vakharia SP
J Am Pharm Assoc (2003); 2023; 63(1):224-229. PubMed ID: 36682855
[TBL] [Abstract][Full Text] [Related]
14. Health care and harm reduction provider perspectives on treating older adults who use non-medical opioids: a qualitative study set in Chicago.
Mason M; Post LA; Aggarwal R
BMC Health Serv Res; 2023 Aug; 23(1):876. PubMed ID: 37598163
[TBL] [Abstract][Full Text] [Related]
15. A pilot study assessing client understanding and use of fentanyl test strips for harm reduction.
Barrolle AA; Gable KN; Dell N
J Am Pharm Assoc (2003); 2023; 63(1):295-300. PubMed ID: 36280433
[TBL] [Abstract][Full Text] [Related]
16. Where Next for Opioids and the Law? Despair, Harm Reduction, Lawsuits, and Regulatory Reform.
Burris S
Public Health Rep; 2018; 133(1):29-33. PubMed ID: 29233069
[No Abstract] [Full Text] [Related]
17. How Should Risks and Benefits of Short-Acting Opioids Be Evaluated in the Care of Inpatients With OUD?
Dong KA; Duthie KM
AMA J Ethics; 2024 Jul; 26(7):E512-519. PubMed ID: 38958419
[TBL] [Abstract][Full Text] [Related]
18. Strategies for Reducing Opioid Deaths.
Aschenbrenner DS
Am J Nurs; 2023 Feb; 123(2):26. PubMed ID: 36698356
[TBL] [Abstract][Full Text] [Related]
19. Rapid Response to the Legalization of Fentanyl Test Strips in Alabama: An Academic-Community Partnership.
McCollum CG; Ventrelli G; Gagnon KW; Loftis A; Famurewa A; Wimberly C; Eaton E
Am J Public Health; 2024 Aug; 114(8):785-788. PubMed ID: 38870434
[TBL] [Abstract][Full Text] [Related]
20. A 2023 Agenda for Substance Use Prevention and Treatment in the US.
Gupta R; Wright NF; Holtgrave DR
JAMA; 2023 Mar; 329(9):707-708. PubMed ID: 36745417
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
